NCT02480881 - A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 7, 2015

Primary Completion Date

January 11, 2016

Study Completion Date

January 11, 2016

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

BMS-663068

Investigational product

DRUG

Oral Contraceptive

Subject's existing combination OC tablet containing EE and progestin

DRUG

Loestrin 1.5/30

OC containing EE and norethindrone acetate (NEA)

Trial Locations (2)

GSK Investigational Site, Miami

GSK Investigational Site, San Antonio